RYUGE AKIHIRO, OZEKI TOSHIKAZU, MINATOGUCHI SHUN, MURAI YUKARI, KAWATO RUI, OZEKI TAKAYA, OYAMA YUKAKO, NOMURA ATSUSHI, TOMINO TATSUHITO, SHIMIZU HIDEAKI, FUJITA YOSHIRO Chubu-Rosai Hospital Introduction: There are few reports concerning tumor lysis syndrome arising from autolysis Doxorubicin purchase of solid cancers.
We describe a recently encountered case of tumor lysis syndrome detected during detailed examination of lung cancer with liver metastasis. Methods & Results: The patient was a 79-year-old male. He was being managed at the Department of Nephrology of our hospital because of chronic kidney disease (Cr: 2.5 mg/dl). Early in April of XXXX, he developed pain involving the right hypochondrial region and anorexia. Because of intense malaise, he visited the outpatient critical care unit of our hospital on April 6. At that time, blood tests revealed marked elevation of
hepatobiliary enzymes, and CT scan disclosed a tumorous lesion approximately 13 cm in size in the right lobe of the liver. He was thus hospitalized to undergo detailed examination. Liver biopsy was performed on the 11th hospital day. Around April 15, his urine volume began to decrease, and blood tests the following day revealed elevation of BUN (60.0 mg/dl) and Cre (3.67 mg/dl), accompanied Veliparib by uric acid elevation (22.2 mg/dl). Renal function did not improve despite fluid therapy. Hemodialysis was thus started on April 18. Thereafter, the uric acid level decreased but urine volume showed no improvement and his general condition gradually deteriorated. The biopsy results allowed a diagnosis of small-cell carcinoma, suggesting that the nodular shadow noted in the right lung represented the primary Bacterial neuraminidase tumor. Treatment
was judged to be difficult in view of his general condition, and the patient was followed without active treatment. He died on April 23. Conclusion: We thus encountered a case of tumor lysis syndrome probably arising from autolysis of small-cell lung carcinoma and an associated metastatic hepatic lesion. RYU HAN JAK1, HAN IN MEE1, HAN JI SUK1, PARK JUNG TAK1, YOO TAE-HYUN1,2, KANG SHIN-WOOK1,2, MOON SUNG JIN3, OH HYUNG JUNG1 1Department of Internal Medicine, College of Medicine, Yonsei University, Seoul; 2Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul; 3College of Medicine, Kwandong University, Gyeonggi-do, Korea Introduction: Platelet size has been demonstrated to reflect platelet activity and to predict poor clinical outcomes in patients with cardiovascular disease. However, the prognostic value of platelet size for mortality has not been studied in patients with acute kidney injury (AKI). Methods: A total of 349 patients who received continuous renal replacement therapy (CRRT) for AKI between August 2009 and October 2011 were divided into two groups based on the median mean platelet volume (MPV) at the time of CRRT initiation.